CD4+ T cells are positively selected in the thymus on peptides presented in the context of major histocompatibility complex class II molecules expressed on cortical thymic epithelial cells. Molecules regulating this peptide presentation play a role in determining the outcome of positive selection. Cathepsin L mediates invariant chain processing in cortical thymic epithelial cells, and animals of the I-Ab haplotype deficient in this enzyme exhibit impaired CD4+ T cell selection. To determine whether the selection defect is due solely to the block in invariant chain cleavage we analyzed cathepsin L–deficient mice expressing the I-Aq haplotype which has little dependence upon invariant chain processing for peptide presentation. Our data indicate the cathepsin L defect in CD4+ T cell selection is haplotype independent, and thus imply it is independent of invariant chain degradation. This was confirmed by analysis of I-Ab mice deficient in both cathepsin L and invariant chain. We show that the defect in positive selection in the cathepsin L−/− thymus is specific for CD4+ T cells that can be selected in a wild-type and provide evidence that the repertoire of T cells selected differs from that in wild-type mice, suggesting cortical thymic epithelial cells in cathepsin L knockout mice express an altered peptide repertoire. Thus, we propose a novel role for cathepsin L in regulating positive selection by generating the major histocompatibility complex class II bound peptide ligands presented by cortical thymic epithelial cells.
Skip Nav Destination
Article navigation
20 May 2002
Article|
May 20 2002
Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain : A Role in the Generation of Positively Selecting Peptide Ligands
Karen Honey,
Karen Honey
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
2Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, WA 98195
Search for other works by this author on:
Terry Nakagawa,
Terry Nakagawa
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
Search for other works by this author on:
Christoph Peters,
Christoph Peters
3Medizinische Molekularbiologie, Abteilung Heamatologie-Onkologie, Klinikum der Albert Ludwigs Universitat Freiburg, 79106 Freiburg, Germany
Search for other works by this author on:
Alexander Rudensky
Alexander Rudensky
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
2Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, WA 98195
Search for other works by this author on:
Karen Honey
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
2Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, WA 98195
Terry Nakagawa
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
Christoph Peters
3Medizinische Molekularbiologie, Abteilung Heamatologie-Onkologie, Klinikum der Albert Ludwigs Universitat Freiburg, 79106 Freiburg, Germany
Alexander Rudensky
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
2Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, WA 98195
Address correspondence to A. Rudensky, Department of Immunology, UW I 604 J, 1959 NE Pacific St., Seattle, WA 98195-7370. Phone: 206-685-9310; Fax: 206-685-3612; E-mail: [email protected]
*
Abbreviations used in this paper: Aβ−/−, MHC class II–deficient mice; BL6, C57BL/6; catL, cathepsin L; catS, cathepsin S; CLIP, class II–associated Ii peptide; cTEC, cortical thymic epithelial cell; HRP, horseradish peroxidase; Ii, invariant chain; RAG, recombination-activating gene.
Received:
November 14 2001
Revision Received:
March 19 2002
Accepted:
April 08 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (10): 1349–1358.
Article history
Received:
November 14 2001
Revision Received:
March 19 2002
Accepted:
April 08 2002
Citation
Karen Honey, Terry Nakagawa, Christoph Peters, Alexander Rudensky; Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain : A Role in the Generation of Positively Selecting Peptide Ligands . J Exp Med 20 May 2002; 195 (10): 1349–1358. doi: https://doi.org/10.1084/jem.20011904
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement